AUSTIN, Texas, May 22, 2012 /PRNewswire/ -- Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan.

SAN FRANCISCO, March 20, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class

ANN ARBOR, Mich., March 14, 2012 /PRNewswire/ -- Everist Genomics (EGI), a rapidly-growing personalized medicine company, today announced the launch of the world's first comprehensive companion

Results of a new study from the University of North Carolina at Chapel Hill may help pave the way to a treatment for a neurogenetic disorder often misdiagnosed as cerebral palsy or autism.

CAMBRIDGE, Mass., Dec. 13, 2011 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.